Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06171399 · ClinicalTrials.gov registry record · NA

Cannabis Edibles Packaging Descriptors Experiment

A NA study of Cannabis Use, sponsored by Wake Forest University Health Sciences.

Completed
Registry status
NA
Development phase
2,521
Enrollment target
1
Study location

NCT06171399 is a NA study of Cannabis Use that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 2,521 participants, above the 222-participant average among 44 other Cannabis Use trials with a reported enrollment target (1036% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06171399, a NA study of Cannabis Use, has completed, sponsored by Wake Forest University Health Sciences.

COMPLETED
Registry status
NA
Development phase
2,521 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to assess differences in perceptions of product appeal, harm, and subsequent willingness to try cannabis edibles products with/without product descriptors of interest.

Conditions Studied

Interventions

  • BEHAVIORAL "All Natural" descriptor
  • BEHAVIORAL "Gluten-free" descriptor
  • BEHAVIORAL "Vegan" descriptor
  • BEHAVIORAL "100% Organic" descriptor
  • BEHAVIORAL "Handcrafted" descriptor

Study Locations (1)

North Carolina

  • Wake Forest University Health Sciences - Winston-Salem

Trial Details

FieldValue
Enrollment Target 2,521 participants
Start Date 2024-03-15
Est. Completion 2024-04-15
Phase NA

Sponsor

Wake Forest University Health Sciences

1,140 total trials

What the Registry Record Tells You About NCT06171399

The ClinicalTrials.gov registry entry for NCT06171399 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2,521 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 222-participant average among 44 other Cannabis Use trials with a reported enrollment target (1036% higher). The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cannabis Use appearing as the primary indexed condition, and to 5 interventions - of which "All Natural" descriptor is the first listed.

NCT06171399 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT06171399 about?

NCT06171399 is a clinical study titled "Cannabis Edibles Packaging Descriptors Experiment". The purpose of this study is to assess differences in perceptions of product appeal, harm, and subsequent willingness to try cannabis edibles products with/without product descriptors of interest.

What is the current status of trial NCT06171399?

This trial is currently completed. It is a NA study. The enrollment target is 2,521 participants. The study started on 2024-03-15. Estimated completion is 2024-04-15.

What conditions does trial NCT06171399 study?

This clinical trial studies the following conditions: Cannabis Use.

What interventions are being tested in trial NCT06171399?

The interventions under investigation include: "All Natural" descriptor (BEHAVIORAL), "Gluten-free" descriptor (BEHAVIORAL), "Vegan" descriptor (BEHAVIORAL), "100% Organic" descriptor (BEHAVIORAL), "Handcrafted" descriptor (BEHAVIORAL).

Who is sponsoring clinical trial NCT06171399?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06171399 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cannabis Use

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.